Intranasal formulations: promising strategy to deliver vaccines.

@article{Riese2014IntranasalFP,
  title={Intranasal formulations: promising strategy to deliver vaccines.},
  author={Peggy Riese and Priya Sakthivel and Stephanie Trittel and Carlos Alberto Guzm{\'a}n},
  journal={Expert opinion on drug delivery},
  year={2014},
  volume={11 10},
  pages={1619-34}
}
INTRODUCTION The emergence of new diseases and the lack of efficient vaccines against numerous non-treatable pathogens require the development of novel vaccination strategies. To date, only a few mucosal vaccines have been approved for humans. This was in part due to i) the use of live attenuated vaccines, which are not suitable for certain groups of individuals, ii) safety concerns derived from implementation in humans of some mucosal vaccines, iii) the poor stability, absorption and… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 102 references

Intranasal formulations Expert Opin

KM Quinn, A Yamamoto, A Costa, polyinosinic et al. Coadministration of
Drug Deliv. • 2014
View 12 Excerpts
Highly Influenced

Coadministration of polyinosinic : Intranasal formulations Expert Opin

KM Quinn, A Yamamoto, A Costa
Drug Deliv • 2014

Similar Papers

Loading similar papers…